ZA978352B - Injection formulations of avermectins and milbemycins. - Google Patents

Injection formulations of avermectins and milbemycins.

Info

Publication number
ZA978352B
ZA978352B ZA9708352A ZA978352A ZA978352B ZA 978352 B ZA978352 B ZA 978352B ZA 9708352 A ZA9708352 A ZA 9708352A ZA 978352 A ZA978352 A ZA 978352A ZA 978352 B ZA978352 B ZA 978352B
Authority
ZA
South Africa
Prior art keywords
milbemycins
avermectins
injection formulations
formulations
injection
Prior art date
Application number
ZA9708352A
Other languages
English (en)
Inventor
Michael Grosse-Bley
Richard Kujanek
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ZA978352B publication Critical patent/ZA978352B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA9708352A 1996-09-18 1997-09-17 Injection formulations of avermectins and milbemycins. ZA978352B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19638045A DE19638045A1 (de) 1996-09-18 1996-09-18 Injektionsformulierungen von Avermectinen und Milbemycinen

Publications (1)

Publication Number Publication Date
ZA978352B true ZA978352B (en) 1998-03-24

Family

ID=7806009

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9708352A ZA978352B (en) 1996-09-18 1997-09-17 Injection formulations of avermectins and milbemycins.

Country Status (18)

Country Link
US (1) US6617314B2 (xx)
EP (1) EP0939638B1 (xx)
JP (1) JP4822196B2 (xx)
KR (1) KR20000035978A (xx)
CN (1) CN1130203C (xx)
AR (1) AR008844A1 (xx)
AT (1) ATE228845T1 (xx)
AU (1) AU750874B2 (xx)
BR (2) BRPI9715298B8 (xx)
CA (1) CA2265952C (xx)
DE (2) DE19638045A1 (xx)
DK (1) DK0939638T3 (xx)
ES (1) ES2184135T3 (xx)
HK (1) HK1022845A1 (xx)
NZ (1) NZ334673A (xx)
PL (1) PL332137A1 (xx)
WO (1) WO1998011902A1 (xx)
ZA (1) ZA978352B (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458373B1 (en) 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US7030155B2 (en) 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
KR20000025762A (ko) * 1998-10-14 2000-05-06 유충식 이버멕틴류의 가용화 조성물
GB9827727D0 (en) * 1998-12-16 1999-02-10 Pfizer Ltd Antiparasitic formulations
GB0000313D0 (en) 2000-01-10 2000-03-01 Astrazeneca Uk Ltd Formulation
AU781682B2 (en) 2000-03-20 2005-06-09 Zoetis Services Llc Sustained-release compositions for parenteral administration
US6872708B2 (en) * 2001-09-10 2005-03-29 Mitsukazu Matsumoto Local injection prescription
US7396819B2 (en) * 2003-08-08 2008-07-08 Virbac Corporation Anthelmintic formulations
WO2005094210A2 (en) 2004-03-12 2005-10-13 The Hartz Mountain Corporation Multi-action anthelmintic formulations
NZ590141A (en) * 2008-06-24 2012-05-25 Merial Ltd Anthelminthic formulations including castor oil and another vegetable oil
PL2396006T3 (pl) 2009-02-16 2013-06-28 Zoetis Llc Preparat zawierający doramektynę w dużej dawce
CN101773467B (zh) * 2010-01-20 2015-09-09 北京大北农动物保健科技有限责任公司 一种美贝霉素或美贝霉素肟的兽用缓释注射液及制备方法
CA2792517C (en) * 2010-03-09 2020-03-24 Janssen Biotech, Inc. Non-aqueous high concentration reduced viscosity suspension formulations
US9072668B2 (en) 2010-03-09 2015-07-07 Janssen Biotech, Inc. Non-aqueous high concentration reduced viscosity suspension formulations of antibodies
US20110223208A1 (en) * 2010-03-09 2011-09-15 Beth Hill Non-Aqueous High Concentration Reduced Viscosity Suspension Formulations
AU2013201479C1 (en) * 2012-03-13 2017-11-09 Elanco New Zealand Long Acting Compositions
CN103417478B (zh) * 2012-05-18 2014-09-10 中国农业科学院兰州畜牧与兽药研究所 一种以水为基质的伊维菌素o/w型注射液及其制备方法
US20170196802A1 (en) * 2016-01-08 2017-07-13 Abon Pharmaceuticals, Llc Long Acting Injectable Formulations
WO2019152808A1 (en) 2018-02-01 2019-08-08 Yale University Compositions and methods for inhibition of nuclear-penetrating antibodies
CN114107097B (zh) * 2021-11-10 2024-03-05 河北兴柏农业科技股份有限公司 一种阿佛曼链霉菌活性孢子的固体发酵工艺

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
OA06863A (fr) * 1980-08-04 1983-02-28 Merck & Co Inc Solubilisation de l'invermectine dans l'eau.
NZ210505A (en) * 1983-12-22 1988-06-30 Merck & Co Inc Parasiticidal compositions containing avermectin or milbemycin derivatives
ES2052173T3 (es) * 1989-04-11 1994-07-01 Pfizer Composiciones inyectables que contienen 25-cyclohexil-avermectina b1.
US6001822A (en) * 1989-04-11 1999-12-14 Pfizer Inc. Antiparasitic formulations
NZ234802A (en) * 1989-08-14 1992-11-25 Merck & Co Inc Long acting injectable formulations comprising an avermectin compound and triacetin. treatment for internal and external parasites of animals
US5055486A (en) 1989-12-22 1991-10-08 American Cyanamid Company 13-alkyl-23-imino derivative of LL-F28249 compounds and their use as endo- and ectoparasiticidal, insecticidal, acaricidal and nematocidal agents
US5030650A (en) 1989-09-11 1991-07-09 American Cyanamid Company 13-halo-23-imino derivatives of LL-F28249 compounds and their use as endo- and ectoparasiticidal, insecticidal, acaricidal and nematocidal agents
ES2086022T3 (es) * 1991-07-23 1996-06-16 American Cyanamid Co Composiciones estables para administracion parenteral y su uso.
ATE180671T1 (de) * 1991-09-30 1999-06-15 Merck & Co Inc Hydrierte rizinusöl-enthaltende injizierbare formulierungen mit verlängerter wirkstoffabgabe
GB2275193A (en) * 1993-02-17 1994-08-24 Merck & Co Inc Formulations for the topical delivery of avermectins
DE4443888A1 (de) * 1994-12-09 1996-06-13 Bayer Ag Dermal applizierbare Formulierungen von Parasitiziden
WO1997011709A1 (en) * 1995-09-25 1997-04-03 Ashmont Holdings Limited Anthelmintic macrocyclic lactone compositions
DE19613972A1 (de) * 1996-04-09 1997-10-16 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl
RU2140737C1 (ru) * 1998-09-22 1999-11-10 Мосин Владимир Александрович Средство для профилактики и лечения паразитарных заболеваний животных
CN1219393A (zh) * 1998-11-13 1999-06-16 王玉万 一种含阿维菌素或伊维菌素的兽用抗寄生虫油剂口服液及其制备方法

Also Published As

Publication number Publication date
JP4822196B2 (ja) 2011-11-24
DE19638045A1 (de) 1998-03-19
CN1130203C (zh) 2003-12-10
AU750874B2 (en) 2002-08-01
BR9712058A (pt) 1999-08-24
AU4621597A (en) 1998-04-14
ATE228845T1 (de) 2002-12-15
BR9712058B1 (pt) 2009-05-05
EP0939638A1 (de) 1999-09-08
CA2265952A1 (en) 1998-03-26
US6617314B2 (en) 2003-09-09
ES2184135T3 (es) 2003-04-01
DE59708905D1 (de) 2003-01-16
BR9715298B1 (pt) 2014-10-14
KR20000035978A (ko) 2000-06-26
CA2265952C (en) 2009-11-17
US20020160967A1 (en) 2002-10-31
BRPI9715298B8 (pt) 2016-04-26
EP0939638B1 (de) 2002-12-04
PL332137A1 (en) 1999-08-30
HK1022845A1 (en) 2000-08-25
DK0939638T3 (da) 2003-03-24
CN1230890A (zh) 1999-10-06
JP2001503029A (ja) 2001-03-06
WO1998011902A1 (de) 1998-03-26
AR008844A1 (es) 2000-02-23
NZ334673A (en) 2000-10-27

Similar Documents

Publication Publication Date Title
ZA978352B (en) Injection formulations of avermectins and milbemycins.
GB2326093B (en) Avermectin formulation
AU3728197A (en) Human telomerase
AU3641597A (en) Methods and compositions comprising r-ibuprofen
GR3026710T3 (en) New antiparasitic agents related to the milbemycins and avermectins.
ZA982159B (en) Administration of an injectable antibiotic in the ear of an animal.
CA2251087A1 (en) Injection formulations of avermectins and milbemycins based on castor oil
ZA994521B (en) Composition containing an opacifier or pearlescent agent and at least one fatty alcohol.
ZA975438B (en) Spray-dried polymer compositions and methods.
AU3882997A (en) Human telomerase gene
AU3480297A (en) Modified mcm-56, its preparation and use
AU5383498A (en) Human chemokine beta-13
AU3472799A (en) Dermatological formulations and methods
AU3759099A (en) Diffusing imager and associated methods
AU4876397A (en) Insecticidal compositions and methods
AU2932197A (en) Benzothiophenes, formulations containing same, and methods
AU2215497A (en) Benzothiophenes, formulations containing same, and methods
GR3032847T3 (en) 13-Substituted milbemycin derivatives, their preparation and use.
GB2332671B (en) Acetals, their preparation and their use
AU4146297A (en) Structure and expression of the alpha-carboxyltransferase subunit of heteromeric-acetyl-coa carboxylase
HUP9903596A3 (en) Injection formulations of avermectins and milbemycins based on castor oil
HUP0000342A3 (en) Preparation of [1s-[1a,2b,3b,4a(s
AU4384497A (en) Insect-repellent formulations
AU9786398A (en) Human dnax interleukin-40 (dil-40)
AU7346796A (en) Cultivator